Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.
about
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trialEffect of smoking on age at the time of coronary artery bypass graft surgery; baseline data results from the ROSETTA-CABG registry.Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanismProfibrinolytic effect of the epigenetic modifier valproic acid in man.Effects of whole-body vibration training on fibrinolytic and coagulative factors in healthy young men.Influence of dietary saturated fat intake on endothelial fibrinolytic capacity in adults.Histone deacetylase inhibition enhances tissue plasminogen activator release capacity in atherosclerotic man.Relation of C-reactive protein to endothelial fibrinolytic function in healthy adults.Self-reported habitual short sleep duration is associated with endothelial fibrinolytic dysfunction in men: a preliminary report.Impaired endogenous fibrinolytic capacity in prehypertensive menExposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease.17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.Endothelial biology in the post-menopausal obese womanVascular PAR-1: activity and antagonism.Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis.Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.Effects of atenolol or losartan on fibrinolysis and von Willebrand factor in hypertensive patients with left ventricular hypertrophy.The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.Vascular dysfunction in chronic obstructive pulmonary disease.Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans.It is time to contend with the endothelial consequences of prehypertension.The Vasculature in Prediabetes.Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.
P2860
Q28677739-0765D09D-4E3A-4E61-B39B-34CD23D21FBBQ31109475-14E9CA7F-14E8-4F0D-91E5-F4DD4E780508Q33574874-2E857E8F-125E-43CD-9179-94D5C572DF20Q34043975-37C5D3FB-8654-4129-B0EE-15C914376901Q34306821-49503530-E5CA-4CC0-AA72-EDB342E88D28Q34761223-FE076ECB-D890-4F91-8521-F4C0DD8FF335Q35170392-9B3F05B6-31C9-44A8-9818-B8DA8816DB15Q35217250-6B7C3BE8-1503-41B5-BD04-A47001271412Q35774550-126C0ACA-F79D-4540-AA4F-612B39C07630Q36526467-100CB94B-0186-4C64-8F3D-B9E1321FE385Q36603502-D70D5E20-4276-46AD-894C-5109D5555220Q36725362-A2DE5B23-FD57-4809-BC4A-2A223D7F56A1Q37170186-5AB8172B-B4AA-407B-9613-290F4BD3D591Q37600721-452D3F78-C6D3-44D8-BD78-920D727BB5D6Q37763262-007D1849-0C7C-4F95-A26E-FFA6CE7FDD08Q37846236-5BB4E2E1-B100-4942-9419-5F5093875364Q42257252-99161F6A-47DB-4912-8876-DDE4AC520C04Q43262220-646D2EBB-71EB-4FE4-9C63-3DC227871837Q43634793-7943F264-6264-43F0-80DE-CDD156C0577AQ45960606-E07B54DC-C3A8-4898-9FC3-830FCE1F6E97Q46578793-985E8B81-48D8-4BD5-BF5C-02EE07485E89Q53643800-24D9E9F6-8B06-4BFE-ACD1-B4CA0A4E7B81Q53695913-F8F6D2F3-BE70-44B4-8A9E-214A54C81BDAQ55491477-3B8C59C7-F4DF-4AA8-BD51-9DBBE508053A
P2860
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Endothelial fibrinolytic capac ...... s with coronary heart disease.
@en
type
label
Endothelial fibrinolytic capac ...... s with coronary heart disease.
@en
prefLabel
Endothelial fibrinolytic capac ...... s with coronary heart disease.
@en
P2093
P1476
Endothelial fibrinolytic capac ...... s with coronary heart disease.
@en
P2093
Christopher A Ludlam
David E Newby
Nicholas A Boon
Simon D Robinson
P304
P356
10.1161/ATVBAHA.107.143248
P407
P577
2007-04-26T00:00:00Z